The Market Fieldbook

Confirming your account

Your account is being prepared. You will be redirected securely in a moment.

The Market Fieldbook

Company Observatory

AORT

Artivion, Inc.

Healthcare · Medical - Devices

Overall research band Weak
Quality Weak
Valuation Very weak
Balance sheet Very weak
Market confirmation Mixed

One-minute company read

What this report can tell you now

What the company does

Artivion, Inc. is a global healthcare company based in Kennesaw, Georgia, that develops, produces, and supplies medical devices and implantable human tissues. Its product portfolio includes BioGlue surgical adhesive, heart preservation services, the PhotoFix bovine pericardial patch, and a range of specialized stent graft systems such as E-xtra, E-nside, E-vita, E-nya, and E-tegra for treating aortic and vascular conditions. Artivion also offers devices for peripheral and renal artery treatments, synthetic vascular grafts, PerClot absorbable hemostat, cardiac laser therapy products, and preservation services like CryoVein and CryoArtery. The company manufactures On-X prosthetic heart valves, CarbonAid CO2 diffusion catheters, Chord-X sutures, and ascyrus medical dissection stents, and provides pyrolytic carbon coating services to other medical device manufacturers. Artivion serves physicians, hospitals, healthcare facilities, and surgical specialists, generating revenue through the sale of its medical devices, implantable tissues, and related services.

The current research profile is Mixed Setup, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

No single strength should be treated as decisive without reviewing the underlying evidence and data status.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

  • Read the latest filing or company update.
  • Check the financial period behind each metric.
  • Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC2.8%Model input; read with the evidence status and period context.
Operating margin6.1%Model input; read with the evidence status and period context.
Revenue CAGR · 4 years10.2%Model input; read with the evidence status and period context.
FCF margin-0.2%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.
Evidence detailSee exact inputs, source context, and model-aware metrics.
HistoryReview score and research changes over time.
MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.